Publication | Closed Access

Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide

VaccinationCancer ImmunosurveillanceBreast Cancer PatientsT-regulatory CellImmunologyTumor ImmunityRegulatory T CellsAntigen ProcessingAutoimmunityT Cell ImmunityImmunotherapyMedicineRadiation Oncology